Demonstration of the expression of CD95 ligand transcript and protein in human placenta

Placenta

Volumn 19, Issue 4, 1998, Pages 269-277

  Zorzi, W ^a   Thellin, O ^a   Coumans, B ^a   Melot, F ^a   Hennen, G ^a   Lakaye, B ^a   Igout, A ^a   Heinen, E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MESSENGER RNA;

ARTICLE; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031966565     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(98)90058-3     Document Type: Article

References (63)

1. Anel A, Simon AK, Auphan N, Buferne M, Boyer C, Golstein P & Schmitt-Verhulst AM (1995) Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones. Eur J Immunol, 25, 3381-3387.
2. Ashany D, Song X, Lacy E, Nikolic-Zugic J, Friedman SM & Elkon KB (1995) Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-I antigen pathway. Proc Natl Acad Sci USA, 92, 11225-11229.
3. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A & Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature, 377, 630-632.
4. Bouzahzah F, Bosseloir A, Heinen E & Simar LJ (1995) Human germinal center CD4+CD57+ T cells act differently on B cells than classical T helper cells. De-D Immunol, 4, 189-197.
5. Chaouat G & Martal J (1996) Cytokines et gestation. In Les cytokines. (Ed.) Cavaillon JM, pp. 471-500. Paris: Masson.
6. Delgado SR, McBey BA, Yamashiro S, Fujita J, Kiso Y & Croy BA (1996) Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J Leuk Biol, 59, 262-269.
7. Donckier V, Wissing M, Bruyns C, Abramowicz D, Lybin M, Vanderhaeghen ML & Goldman M (1995) Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation, 59, 1571-1576.
8. Douglas GC & King BF (1989) Isolation of the pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods, 119, 259-268.
9. Ford AL, Foulcher E, Goodsall AL & Sedgwick JD (1996) Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J Immunol Methods, 194, 71-75.
10. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C & Tschopp J (1996) Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol, 133, 335-343.
11. Gotlieb WH (1992) Immunologie de la grossesse. Revue Médicale de Bruxelles, 13, 97-101.
12. Griffith TS, Brunner T, Fletcher SM, Green DR & Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270, 1189-1192.
13. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F et al. (1995) FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity, 2, 341-351.
14. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bornand T, MacDonald HR & Tschopp J (1996) Activated B cells express functional Fas ligand. Eur J Immunol, 26, 721-724.
15. Hebestreit H, Yousefi S, Balatti I, Weber M, Crameri R, Simon D, Hartung K, Schapowal A, Blaser K & Simon HU (1996) Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol, 26, 1775-1780.
16. Heeg K & Wagner H (1990) Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigenreactive Lyt-2+ T cells. J Exp Med, 172, 719-728.
17. Holmes CH, Simpson KL, WainWright SD, Tate CG, Houlihan JM, Sawyer IH, Rogers IP, Spring FA, Anstee D J & Tanner MJ (1990) Preferential expression of the complement regulatory protein Decay Accelerating Factor at the fetomaternal interface during human pregnancy. J Immunol, 144, 3099-3115.
18. Hutter H, Hammer A, Blaschitz A, Hartmann M, Ebbesen P, Dohr G, Ziegler A & Uchanska-Ziegler B (1996) Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res, 286, 439-447.
19. Jaffe EA (1984) Biology of Endothelial Cells. Boston: Martinus Nijhoff Publishers.
20. Johnson PM, Risk JM, Mwenda JM et al. (1990) Human trophoblast expression of retroviral like activity and CD46 (membrane cofactor protein, Hu Ly-m5 and H316 TLX antigen). In Reproductive Immunology (Ed.) Mettler L & Billington WD, pp. 125-131. Amsterdam: Elsevier Science.
21. Jones LA, Chin LT, Merriam GR, Nelson LM & Kruisbeck AM (1990) Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy. J Exp Med, 172, 1277-1285.
22. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG & Loke YW (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol, 156, 2068-2076.
23. Kliman HK, Nestler JE, Sermasi E, Sanger JM & Strauss III, J F (1986) Purification, characterization and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118, 1567-1582.
24. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ & DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science, 248, 220-223.
25. Lachapelle MH, Miron P, Hemmings R, Falcone T, Granger L, Bourque J, & Langlais J (1993) Embryonic resistance to tumour necrosis factor-alpha mediated cytotoxicity: novel mechanism underlying maternal immunological tolerance to the fetal allograft. Hum Reprod, 8, 1032-1038.
26. Letellier C, Fizet D, Baltz T & Vezon G (1994) Immunosuppressive activity of sera of pregnant women on cytotoxic T-lymphocyte-mediated cytolysis. I. Characterization of the active fraction. Gynecol Obstet Invest, 37, 1-5.
27. Lin H, Mossmann TR, Guilbert L, Tuntipopipat S & Wegmann TG (1993) Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol, 151, 4562-4573.
28. Liu CC, Walsh CM, Eto N, Clark WR & Young JDE (1995) Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. J Immunol, 155, 602-608.
29. Lowin B, Hahne M, Mattman C & Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature, 370, 650-652.
30. Lowin B, Mattman C, Hahne M & Tschopp J (1996) Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol, 8, 57-63.
31. Luciani MF & Golstein P (1994) Fas-based d10S-mediated cytotoxicity requires macromolecular synthesis for effector cell activation but not for target cell death. Philos Trans R Soc London B: Biol Sci, 345, 303-309.
32. Maymon R, Zitzer P, Manor Y, Bukovsky I & Moroz C (1995) Placental isoferritin patterns during normal first trimester and tubal gestations. Hum Reprod, 10, 2445-2447.
33. McLaughlin PJ, Cheng MH, Slade MB & Johnson PM (1982) Expression on cultured human tumour cells of placental trophoblast membrane antigens and placental alkaline phosphatase defined by monoclonal antibodies. Int J Cancer, 30, 21-26.
34. McLaughlin PJ, Travers PJ, McDicken IW & Johnson PM (1984a) Demonstration of placental and placental-like alkaline phosphatase in non-malignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay. Clin Chem Acta, 137, 341-348.
35. McLaughlin PJ, Twist AM, Evans CC & Johnson PM (1984b) Serum placental type alkaline phosphatase in cigarette smokers. J Clin Pathol, 37, 826-828.
36. McLaughlin PJ, Lewis-Jones I, Hutchinson GE & Johnson PM (1986) Placental-type alkaline phosphatase in human seminal plasma from fertile and infertile men. Fert Ster, 46, 934-937.
37. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S & Taniguchi N (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol, 149, 3753-3758.
38. Morrish DW, Shaw ARE, Seehafer J, Bhardwaj D & Paras M T (1991) Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen. In Vitro Cell Devl Biol, 27A, 303-306.
39. Nagata S & Golstein P (1995) The Fas death factor. Science, 267, 1449-1456.
40. Novelli F, Bernabei P, Ozmen L, Rigamonti L, Allione A, Pestka S, Garotta G & Forni G (1996) Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J Immunol, 157, 1935-1943.
41. Petraglia F, Florio P, Nappi C & Genazzani AR (1996) Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev, 17, 156-186.
42. Quigley RL, Wood KJ & Morris PJ (1989) Transfusion induces blood donor-specific suppressor cells. J Immunol, 142(2), 463-470.
43. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy M K & Lynch DH (1994) Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol, 6, 1545-1553.
44. Richardson BC, Lalwani ND, Johnson KJ & Marks RM (1994) Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol, 24, 2640-2645.
45. Rouvier E, Luciani MF & Golstein P (1993) Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med, 177, 195-200.
46. Runic R, Lockwood CJ, Ma Y, Dipasquale B & Guller S (1996) Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab, 81, 3119-3122.
47. Saoudi A, Kuhn J, Huygen K, De Kozak Y, Velu T, Goldman M, Druet P & Bellon B (1993) Th2 activated cells prevent experimental autoimmune uveoretinitis, a Thl-dependent autoimmune disease. Eur J Immunol, 23, 3096-3103.
48. Schandene L, Ferster A, Mascart-Lemone F, Crusiaux A, Gerard C, Marchant A, Lybin M, Velu T, Sariban E & Goldman M (1993) T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol, 23, 56-60.
49. Schattner EJ, Mascarenhas J, Bishop J, Yoo DH, Chadburn A, Crow MK & Friedman SM (1996) CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood, 88, 1375-1382.
50. Smith MA, Lucie NP & Ferguson M (1986) Progesterone inhibits proliferation of human marrow colony forming cells (CFU-GM) through increased prostaglandin production by marrow macrophages. Br J Haematol, 63, 649-658.
51. Suda T & Nagata S (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med, 179, 873-879.
52. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K & Nagata S (1995) Expression of the Fas ligand in cells of T cell lineage. J Immunol, 154, 3806-3813.
53. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T & Nagata S (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol, 6, 1567-1574.
54. Tanaka M, Suda T, Takahashi T & Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBOJ, 14, 1129-1135.
55. Tucek-Szabo CL, Andjelic S, Lacy E, Elkon KB & Nikolic-Zugic J (1996) Activation-induced death can occur without Fas receptor. J Immunol, 156, 192-200.
56. Uckan D, Steele A, Cherry O, Wang B, Chamizo W, Koutsonikolis A & Good RA (1997) Fas (CD95), Fas ligand (CD95-L), and Bcl-2 expression in human placenta and umbilical cord. J Aller Clin Immunol, 99, S27.
57. Vaux DL & Strasser A (1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA, 93, 2239-2244.
58. Vignaux F & Golstein P (1994) Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol, 24, 923-927.
59. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S & Golstein P (1995) TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med, 181, 781-786.
60. Webb S, Morris C & Sprent J (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell, 63, 1249-1256.
61. Wegmann TG (1984) Fetal protection against abortion: is it immunosuppression or immunostimulation? Ann d' Immunol, 135D, 309-311.
62. Wegmann TG, Lin H, Guilbert L & Mosmann TR (1993) Bi-directional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today, 14, 353-356.
63. Williams GH, McLaughlin PJ & Johnson PM (1986) Tissue origin of serum placental-like alkaline phosphatase in cigarette smokers. Clin Chim Acta, 155, 329-334.